Logo image of NVX

NOVONIX LTD-ADR (NVX) Stock Fundamental Analysis

NASDAQ:NVX - Nasdaq - US67010L1008 - ADR - Currency: USD

1.01  -0.02 (-2.42%)

After market: 1.02 +0.01 (+0.99%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NVX. NVX was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. NVX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, NVX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NVX had negative earnings in the past year.
In the past year NVX has reported a negative cash flow from operations.
NVX had negative earnings in each of the past 5 years.
NVX had a negative operating cash flow in each of the past 5 years.
NVX Yearly Net Income VS EBIT VS OCF VS FCFNVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

NVX has a Return On Assets of -33.09%. This is amonst the worse of the industry: NVX underperforms 80.00% of its industry peers.
NVX has a worse Return On Equity (-54.38%) than 78.40% of its industry peers.
Industry RankSector Rank
ROA -33.09%
ROE -54.38%
ROIC N/A
ROA(3y)-22.59%
ROA(5y)-20.43%
ROE(3y)-33.39%
ROE(5y)-27.76%
ROIC(3y)N/A
ROIC(5y)N/A
NVX Yearly ROA, ROE, ROICNVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

NVX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NVX Yearly Profit, Operating, Gross MarginsNVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K

More info and screens

1

2. Health

2.1 Basic Checks

NVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
NVX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NVX has more shares outstanding
Compared to 1 year ago, NVX has a worse debt to assets ratio.
NVX Yearly Shares OutstandingNVX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVX Yearly Total Debt VS Total AssetsNVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -0.90, we must say that NVX is in the distress zone and has some risk of bankruptcy.
NVX has a worse Altman-Z score (-0.90) than 84.00% of its industry peers.
NVX has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.29, NVX is doing worse than 60.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z -0.9
ROIC/WACCN/A
WACC7.57%
NVX Yearly LT Debt VS Equity VS FCFNVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

NVX has a Current Ratio of 1.24. This is a normal value and indicates that NVX is financially healthy and should not expect problems in meeting its short term obligations.
NVX has a worse Current ratio (1.24) than 85.60% of its industry peers.
NVX has a Quick Ratio of 1.21. This is a normal value and indicates that NVX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.21, NVX is doing worse than 70.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 1.21
NVX Yearly Current Assets VS Current LiabilitesNVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for NVX have decreased strongly by -54.32% in the last year.
The Revenue for NVX has decreased by -15.76% in the past year. This is quite bad
Measured over the past years, NVX shows a very strong growth in Revenue. The Revenue has been growing by 20.91% on average per year.
EPS 1Y (TTM)-54.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.43%
Revenue 1Y (TTM)-15.76%
Revenue growth 3Y13.64%
Revenue growth 5Y20.91%
Sales Q2Q%-24.68%

3.2 Future

Based on estimates for the next years, NVX will show a very negative growth in Earnings Per Share. The EPS will decrease by -33.09% on average per year.
Based on estimates for the next years, NVX will show a very strong growth in Revenue. The Revenue will grow by 66.08% on average per year.
EPS Next Y-9.09%
EPS Next 2Y4.45%
EPS Next 3Y-72.6%
EPS Next 5Y-33.09%
Revenue Next Year-36.01%
Revenue Next 2Y297.29%
Revenue Next 3Y52.37%
Revenue Next 5Y66.08%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVX Yearly Revenue VS EstimatesNVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
NVX Yearly EPS VS EstimatesNVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVX Price Earnings VS Forward Price EarningsNVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVX Per share dataNVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

NVX's earnings are expected to decrease with -72.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.45%
EPS Next 3Y-72.6%

More info and screens

0

5. Dividend

5.1 Amount

NVX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NOVONIX LTD-ADR

NASDAQ:NVX (6/30/2025, 8:00:02 PM)

After market: 1.02 +0.01 (+0.99%)

1.01

-0.02 (-2.42%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)08-20 2025-08-20
Inst Owners7.71%
Inst Owner Change-30.72%
Ins Owners3.57%
Ins Owner ChangeN/A
Market Cap160.60M
Analysts84
Price Target1.55 (53.47%)
Short Float %0.33%
Short Ratio4.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.78%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.67
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB 1.28
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.04
BVpS0.87
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.09%
ROE -54.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.59%
ROA(5y)-20.43%
ROE(3y)-33.39%
ROE(5y)-27.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 442.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 1.21
Altman-Z -0.9
F-Score2
WACC7.57%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)612.3%
Cap/Sales(5y)464.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-54.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.43%
EPS Next Y-9.09%
EPS Next 2Y4.45%
EPS Next 3Y-72.6%
EPS Next 5Y-33.09%
Revenue 1Y (TTM)-15.76%
Revenue growth 3Y13.64%
Revenue growth 5Y20.91%
Sales Q2Q%-24.68%
Revenue Next Year-36.01%
Revenue Next 2Y297.29%
Revenue Next 3Y52.37%
Revenue Next 5Y66.08%
EBIT growth 1Y-7.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.45%
EBIT Next 3Y14.1%
EBIT Next 5Y13.32%
FCF growth 1Y-27.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.11%
OCF growth 3YN/A
OCF growth 5YN/A